Our data uncovered that PDS5B upregulation elevated the expression of LATS1 in H1975 and H460 cells, whereas PDS5B silencing alleviated the LATS1 expression levels in NSCLC cells (Figs. 3A, B). This evidence concerns the gene LATS1 and non-small cell lung carcinoma.